Stocks / Biotech
NVAXBiotech
Novavax Inc
$10.031d +7.0%5d +9.0%settled close · 2026-09-17
Mkt cap $1.5B (3/25)β 1.8552w $7.30–11.09Shares 162.9MInd. Biological Products, (No Diagnostic Substances)Nasdaq since 1995Emp. 749HQ Gaithersburg, MDnovavax.com
Who’s talkingIdea Scout · free
Who’s talking about NVAX
No tracked investor commentary on NVAX yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 4 Nov 2026
Confirmed date · consensus EPS -0.24. Reactions below are the next settled session over the prior close.
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where NVAX’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 7 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-01 | ||||||
| 2026-08-26 | ||||||
| 2026-08-25 | ||||||
| 2026-08-21 | ||||||
| 2026-08-19 | ||||||
| 2026-07-10 | ||||||
| 2026-05-27 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
NVAX is in this morning’s Brief.
Get The Brief — $20/mo →